Intelligence · Clinical Development
Pipeline search results
Programs matching “qing” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 138 pipeline programs matching "qing" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
PBCAR19B
Chongqing Precision Biotech Co., Ltd
CD19 Expressing Malignancies
1 trial -
PBCAR269A
Chongqing Precision Biotech Co., Ltd
Relapsed/Refractory Multiple Myeloma
1 trial -
PBGENE-HBV
Chongqing Precision Biotech Co., Ltd
HEPATITIS B CHRONIC
1 trial -
PBGENE-HBV-01
Chongqing Precision Biotech Co., Ltd
Chronic Hepatitis B
1 trial -
PIC1 Injection
Chongqing Precision Biotech Co., Ltd
Non-Hodgkin Lymphoma
1 trial -
PRAX-628
Chongqing Precision Biotech Co., Ltd
Healthy
1 trial -
PRAX-628-102
Chongqing Precision Biotech Co., Ltd
Epilepsy
1 trial -
PTOC1
Chongqing Precision Biotech Co., Ltd
Systemic Lupus Erythematosus
1 trial -
Qing'E pill
Shanghai University of Traditional Chinese Medicine
Menopause
1 trial -
RUC-4 Compound
Chongqing Precision Biotech Co., Ltd
Coronary Disease
1 trial -
TAEST16001
Chongqing Precision Biotech Co., Ltd
Liver Cancer Stage IV
1 trial -
TAEST16001 cells
Chongqing Precision Biotech Co., Ltd
Soft Tissue Sarcoma
1 trial -
TQF3250 placebo
Chia Tai Tianqing Pharmaceutical Group Co.,
Hyperglycemia
1 trial -
Targeted CEA CAR-T
Chongqing Precision Biotech Co., Ltd
Advanced Lung Cancer
4 trials -
Yinhu Qingwen Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Viral Pneumonia
1 trial -
[11C]CPPC Injection
Chongqing Precision Biotech Co., Ltd
Amyotrophic Lateral Sclerosis
1 trial -
anti-BCMA/CD70-CAR-T cells
Chongqing Precision Biotech Co., Ltd
CAR T Cell Therapy
1 trial -
anti-CD19 CAR NK
Chongqing Precision Biotech Co., Ltd
NHL
1 trial -
anti-CD19-CAR-T cells
Chongqing Precision Biotech Co., Ltd
Systemic Lupus Erythematosus
1 trial -
pCAR-19B cells
Chongqing Precision Biotech Co., Ltd
Acute Lymphoblastic Leukemia, in Relapse
1 trial -
BLB-750 Vaccine (Qinghai RG strain)
Takeda
Pandemic Influenza Prevention
1 trial -
Dexamethasone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Localized Primary Osteoarthritis of Both Hips (Diagnosis)
1 trial -
Hepatitis B vaccine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Hepatitis B Vaccination, HIV
1 trial -
Provase
Chongqing Precision Biotech Co., Ltd
Pruritus
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.